Eric Wombwell - Pharmacology of Infectious Disease: Essential Elements for an Impactful Clinical Pharmacy Practice

Dr. Eric Wombwell, PharmD, and Board Certified Infectious Disease Pharmacist will be your guide in this seminar, as you learn the latest evidence in the ph...

New SunLurn v2024

Store URL: https://SunLurn.one

21.000+ INSTANT DOWNLOAD PRODUCT

$18.00 $99.99
Immediate Download after purchase

Information

Faculty:
Eric Wombwell
Duration:
Approx. 6 Hours
Copyright:
Feb 15, 2021

Description

Dr. Eric Wombwell, PharmD, and Board Certified Infectious Disease Pharmacist will be your guide in this seminar, as you learn the latest evidence in the pharmacology of infectious diseases and application of this evidence to enhance your clinical pharmacy practice. 

With new antibiotics, vaccines, treatment guidelines, and evidence-based research continuously becoming available, the need to stay up-to-date is an imperative for pharmacists.  The CDC recommends that pharmacists receive ongoing education about a variety of areas, including adverse reactions to antibiotics, antibiotic resistance and optimal prescribing.

Dr. Wombwell will draw attention to clinical situations where antibiotics are overprescribed, unnecessarily used, and underutilized in the treatment of infections. He will provide approaches to improve antibiotic use in these situations—resulting in reduced antibiotic cost, resistance, and collateral damage, improving patient outcomes in both outpatient and inpatient environments.

You’ll leave with the knowledge and strategies to:  

  • Integrate current, best-practice treatment guidelines
  • Limit adverse reactions from antibiotics
  • Implement antimicrobial de-escalation strategies
  • And more!

Purchase this seminar, and as an added bonus, you’ll receive FREE access to the seminar Pharmacology of Pain Management for End-of-Life Care: Recommendations for Advanced Clinical Pharmacy Practice to build your knowledge about the pharmacology surrounding pain and comfort.

The need for robust antibiotic stewardship has never been more pressing.  Purchase today!

Please click here to view hardware, software and internet connectivity requirements for this program.

Outline

Considerations for Successful Empiric Therapy

  • Spectrum of activity for commonly used antibiotics
  • Normal flora for infectious sites
  • Resistance associated with common bacteria
  • Pharmacodynamic influences on antibiotic dosing

Interpretation of Microbiologic Test Results 

  • Gram stain results
  • Culture and sensitivity results
  • Minimum inhibitory concentration (MIC) evaluation
  • PCR results

Antibacterial Resistance

  • Trends
  • Mechanisms of resistance
  • Contributing factors
  • Antibiotic stewardship concepts

Antibiotic Related Allergies– Penicillin and ‘Sulfa’

  • Define true allergy versus side effect
  • Penicillin allergy and cephalosporin cross sensitivity 
  • ‘Sulfa’ allergy

SARS-CoV-2

  • Clinical trial data for therapeutics
  • Clinical trial data for vaccines

Skin and Soft Tissue Infections

  • Streptococcus pyogenes vs. MRSA
  • Evidence for antibiotic management
  • IDSA treatment guidelines
  • Vancomycin AUC/MIC monitoring

Pneumonia

  • Evidence for pathogen etiology
  • Evidence for antibiotic management
  • IDSA/ATS community-acquired pneumonia treatment guidelines
  • Resistance risk factors and management
  • IDSA/ATS hospital- and ventilator-acquired pneumonia treatment guidelines
  • New antibiotics for MDR infections

Influenza

  • Evidence on vaccine timing and use in older adults
  • Clinical trial data for therapeutics
  • IDSA/CDC treatment guidelines

Urinary Tract Infections

  • Resistance trends
  • Clinical trial data for therapeutics
  • Antibiotics for MDR infections

Clostridium Difficile Infection

  • Risk factor literature review
  • Compare antibiotic risk levels
  • IDSA treatment guidelines
  • Clinical trial data for therapeutics
  • Probiotics prophylaxis evidence review
     

Faculty

Eric Wombwell, PharmD, BCIDP Related seminars and products: 4


Eric Wombwell, PharmD, BCIDP, is a board certified infectious diseases pharmacist and Clinical Associate Professor for the Department of Pharmacy Practice and Administration at the University of Missouri - Kansas City, School of Pharmacy. Wombwell is responsible for developing clinical and educational initiatives designed to optimize student learning. He is active in lecturing, research and hospital pharmacy practice.

Dr. Wombwell completed his PharmD degree at the University of Missouri Kansas City, followed by an ASHP accredited pharmacy practice residency at the Kansas City VA Medical Center. Upon residency completion, Wombwell accepted a full-time non-tenured clinical faculty position at the University of Missouri - Kansas City, School of Pharmacy. His responsibilities include teaching Doctor of Pharmacy students in a variety of courses, with special emphasis in the area of infectious diseases. As part of this position, Wombwell serves as a Clinical Pharmacy Specialist, working as part of the multidisciplinary team, providing care to acutely ill patients at Centerpoint Medical Center in Independence, Missouri. In addition, Wombwell functions in an adjunct faculty capacity with the University of Missouri - Kansas City, School of Dentistry, where he is responsible for teaching infectious diseases curricular content to dental students in the Pharmacology and Therapeutics course series.

Dr. Wombwell has more than 20 peer-reviewed publications on pharmacy and medication-related topics, and has delivered more than 50 invited presentations locally and nationally for continuing education to various health-professional audiences. He has been named Teacher-of-the-Year in various capacities 7 times, "Missouri Pharmacist Association - UMKC Faculty Member of the Year" in 2016, and received the "UMKC Provost's Award for Excellence in Teaching" in 2014.

Speaker Disclosures:

Financial: Eric Wombwell is a Clinical Assistant Professor, Department of Pharmacy Practice at the University of Missouri – Kansas City. He receives a speaking honorarium from PESI, Inc.

Non-financial: Eric Wombwell has no relevant nonfinancial relationships to disclose.